• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion.人免疫缺陷病毒1型包膜蛋白(Env)、CD4和趋化因子受体的三元复合物形成,被捕获为膜融合的中间体。
J Virol. 2005 Sep;79(17):11161-9. doi: 10.1128/JVI.79.17.11161-11169.2005.
2
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.在HIV-1包膜介导的融合过程中,CXCR4与gp120结合后,HIV-1 gp41六螺旋束迅速形成。
Biochemistry. 2001 Oct 16;40(41):12231-6. doi: 10.1021/bi0155596.
3
The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.CCR5的N端片段在HIV-1包膜糖蛋白介导的膜融合中的作用以及病毒对缺失该片段的CCR5的适应机制。
Retrovirology. 2007 Aug 8;4:55. doi: 10.1186/1742-4690-4-55.
4
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.人类免疫缺陷病毒1型(HIV-1)对进入抑制剂的敏感性与包膜/共受体亲和力、受体密度及融合动力学相关。
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16249-54. doi: 10.1073/pnas.252469399. Epub 2002 Nov 20.
5
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.细胞间融合过程中人类免疫缺陷病毒包膜的抗原特性。
J Virol. 2001 Nov;75(22):11096-105. doi: 10.1128/JVI.75.22.11096-11105.2001.
6
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.胞质尾部减缓了人类免疫缺陷病毒1型Env从晚期前聚体构型折叠成六螺旋束的过程。
J Virol. 2005 Jan;79(1):106-15. doi: 10.1128/JVI.79.1.106-115.2005.
7
Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.细胞间融合过程中人类免疫缺陷病毒跨膜糖蛋白的抗原特性
J Virol. 2002 Dec;76(23):12123-34. doi: 10.1128/jvi.76.23.12123-12134.2002.
8
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.具有亚基间二硫键的1型人类免疫缺陷病毒Env与共受体结合,但结合后需要还原二硫键以诱导融合。
J Virol. 2003 May;77(10):5829-36. doi: 10.1128/jvi.77.10.5829-5836.2003.
9
Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.人血单核细胞衍生树突状细胞中CCR5和CXCR4与CD4及gp120的相互作用
Exp Mol Pathol. 2000 Jun;68(3):133-8. doi: 10.1006/exmp.1999.2300.
10
Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.HIV-1和HIV-2包膜糖蛋白介导的融合的动力学研究。
Retrovirology. 2006 Dec 4;3:90. doi: 10.1186/1742-4690-3-90.

引用本文的文献

1
Electron tomography visualization of HIV-1 fusion with target cells using fusion inhibitors to trap the pre-hairpin intermediate.利用融合抑制剂捕获发夹前中间体来可视化 HIV-1 与靶细胞融合的电子断层扫描。
Elife. 2020 Jul 22;9:e58411. doi: 10.7554/eLife.58411.
2
HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry.HIV-1 锚定抑制剂和膜融合抑制剂针对病毒进入的不同但重叠的步骤。
J Biol Chem. 2019 Apr 12;294(15):5736-5746. doi: 10.1074/jbc.RA119.007360. Epub 2019 Jan 29.
3
The β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion Mechanisms.β-内酰胺酶测定:利用荧光共振能量转移生物传感器分析病毒融合机制。
Sensors (Basel). 2016 Jun 23;16(7):950. doi: 10.3390/s16070950.
4
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.与马拉维若耐药相关的HIV-1 V3环中的单残基变化会损害CCR5结合亲和力,同时增加复制能力。
Retrovirology. 2015 Jun 18;12:50. doi: 10.1186/s12977-015-0177-1.
5
Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.与靶细胞结合的病毒粒子上人类免疫缺陷病毒包膜糖蛋白gp120的抗原特性。
PLoS Pathog. 2015 Mar 25;11(3):e1004772. doi: 10.1371/journal.ppat.1004772. eCollection 2015 Mar.
6
Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion.HIV与细胞融合及HIV介导的细胞间融合的不同要求。
J Biol Chem. 2015 Mar 6;290(10):6558-73. doi: 10.1074/jbc.M114.623181. Epub 2015 Jan 14.
7
Designer antigens for elicitation of broadly neutralizing antibodies against HIV.设计用于诱导针对 HIV 的广泛中和抗体的抗原。
Clin Transl Immunology. 2014 Sep 26;3(9):e24. doi: 10.1038/cti.2014.22. eCollection 2014 Sep.
8
Significant differences in cell-cell fusion and viral entry between strains revealed by scanning mutagenesis of the C-heptad repeat of HIV gp41.通过对 HIV gp41 的 C 七肽重复序列的扫描诱变揭示了株间细胞融合和病毒进入的显著差异。
Biochemistry. 2013 May 21;52(20):3552-63. doi: 10.1021/bi400201h. Epub 2013 May 7.
9
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.逃避人类免疫缺陷病毒 1 型(HIV-1)进入抑制剂。
Viruses. 2012 Dec;4(12):3859-911. doi: 10.3390/v4123859.
10
Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin.人α-防御素抑制 HIV-1 进入的多方面机制。
J Biol Chem. 2012 Aug 17;287(34):28821-38. doi: 10.1074/jbc.M112.375949. Epub 2012 Jun 25.

本文引用的文献

1
Stoichiometry of antibody neutralization of human immunodeficiency virus type 1.1型人类免疫缺陷病毒抗体中和的化学计量学
J Virol. 2005 Mar;79(6):3500-8. doi: 10.1128/JVI.79.6.3500-3508.2005.
2
Structure of an unliganded simian immunodeficiency virus gp120 core.未结合配体的猿猴免疫缺陷病毒糖蛋白120核心的结构。
Nature. 2005 Feb 24;433(7028):834-41. doi: 10.1038/nature03327.
3
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.873140是一种有效的变构非竞争性HIV进入抑制剂,其基于CCR5受体的作用机制。
Mol Pharmacol. 2005 Apr;67(4):1268-82. doi: 10.1124/mol.104.008565. Epub 2005 Jan 11.
4
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.胞质尾部减缓了人类免疫缺陷病毒1型Env从晚期前聚体构型折叠成六螺旋束的过程。
J Virol. 2005 Jan;79(1):106-15. doi: 10.1128/JVI.79.1.106-115.2005.
5
The differential sensitivity of human and rhesus macaque CCR5 to small-molecule inhibitors of human immunodeficiency virus type 1 entry is explained by a single amino acid difference and suggests a mechanism of action for these inhibitors.人类和恒河猴CCR5对1型人类免疫缺陷病毒进入的小分子抑制剂的差异敏感性可由一个氨基酸差异来解释,并提示了这些抑制剂的作用机制。
J Virol. 2004 Apr;78(8):4134-44. doi: 10.1128/jvi.78.8.4134-4144.2004.
6
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor.1型人类免疫缺陷病毒对小分子CCR5抑制剂逃逸的遗传与表型分析
J Virol. 2004 Mar;78(6):2790-807. doi: 10.1128/jvi.78.6.2790-2807.2004.
7
Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions.对HIV和猴免疫缺陷病毒病毒粒子上包膜糖蛋白三聚体的电子断层扫描分析。
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15812-7. doi: 10.1073/pnas.2634931100. Epub 2003 Dec 10.
8
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.AMD3100对CXCR4受体拮抗作用的分子机制:结合位点向CXCR3受体的转移。
J Biol Chem. 2004 Jan 23;279(4):3033-41. doi: 10.1074/jbc.M309546200. Epub 2003 Oct 28.
9
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.CXCR4与反向激动剂和弱部分激动剂的脂质双分子层模拟
J Biol Chem. 2003 Nov 21;278(47):47136-44. doi: 10.1074/jbc.M307850200. Epub 2003 Sep 4.
10
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.针对AMD3100的CXCR4相互作用位点的突变会影响抗CXCR4抗体的结合以及HIV-1的进入。
FEBS Lett. 2003 Jul 10;546(2-3):300-6. doi: 10.1016/s0014-5793(03)00609-4.

人免疫缺陷病毒1型包膜蛋白(Env)、CD4和趋化因子受体的三元复合物形成,被捕获为膜融合的中间体。

Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion.

作者信息

Mkrtchyan Samvel R, Markosyan Ruben M, Eadon Michael T, Moore John P, Melikyan Gregory B, Cohen Fredric S

机构信息

Department of Molecular Biophysics and Physiology, Rush University Medical Center, Chicago, IL 60612, USA.

出版信息

J Virol. 2005 Sep;79(17):11161-9. doi: 10.1128/JVI.79.17.11161-11169.2005.

DOI:10.1128/JVI.79.17.11161-11169.2005
PMID:16103167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1193594/
Abstract

Human immunodeficiency virus (HIV) Env-induced fusion is highly temperature dependent. When effector and target cells were coincubated at 37 degrees C, there was a kinetic delay before fusion commenced. When effector and target cells were coincubated for varied times at 23 degrees C, a temperature that does not permit fusion, a temperature-arrested stage was created. Raising temperature to 37 degrees C from the 23 degrees C intermediate eliminated the kinetic delay. Inhibitors (T22, AMD3100, and Sch-C) that block fusion by binding chemokine receptors were added after creating the intermediate so as to assess the extent of engagement between gp120 and chemokine receptors at that stage. For both CXCR4 and CCR5 as coreceptors, increasingly long times of coincubation at 23 degrees C reduced the efficacy of the coreceptor-binding inhibitors in blocking fusion. This implies that an increasing number of ternary Env/CD4/coreceptor complexes form over time at 23 degrees C. It also shows that ternary complex formation has a lower temperature threshold than the downstream steps that include Env folding into a six-helix bundle; this provides an experimental means to separate coreceptor binding by gp120 from the subsequent refolding of gp41 into a six-helix bundle structure. As the time of cell coincubation at 23 degrees C was prolonged, more cells quickly fused upon the raising of the temperature to 37 degrees C, and the increase quantitatively correlated with the greater percentage of fusion that was resistant to drugs. Therefore the pronounced kinetic delay in HIV Env-induced fusion is caused predominantly by the time needed for ternary complexes to form.

摘要

人类免疫缺陷病毒(HIV)Env诱导的融合高度依赖温度。当效应细胞和靶细胞在37℃共同孵育时,融合开始前存在动力学延迟。当效应细胞和靶细胞在23℃(一个不允许融合的温度)共同孵育不同时间时,会形成一个温度停滞阶段。将温度从23℃升至37℃可消除动力学延迟。在形成中间阶段后添加通过结合趋化因子受体来阻断融合的抑制剂(T22、AMD3100和Sch-C),以评估该阶段gp120与趋化因子受体之间的结合程度。对于作为共受体的CXCR4和CCR5,在23℃下共同孵育的时间越长,共受体结合抑制剂阻断融合的效力越低。这意味着在23℃下随着时间推移会形成越来越多的三元Env/CD4/共受体复合物。这也表明三元复合物形成的温度阈值低于包括Env折叠成六螺旋束在内的下游步骤;这提供了一种实验手段,可将gp120与共受体的结合与gp41随后重折叠成六螺旋束结构区分开来。随着在23℃下细胞共同孵育时间的延长,当温度升至37℃时更多细胞会迅速融合,且这种增加在数量上与对药物耐药的融合百分比增加相关。因此,HIV Env诱导融合中明显的动力学延迟主要是由三元复合物形成所需的时间引起的。